Prostate cancer Board decisions

The Veteran has withdrawn his appeals for the issues of service connection for an acquired psychiatric disorder, heart disability, and prostate cancer, as well as TDIU. The appeal is dismissed.

The Board has determined that the Veteran's prostate cancer with erectile dysfunction is no longer rated at 100 percent due to remission, and a 20 percent rating is assigned effective January 1, 2014. The reduction from 100 percent was proper.

The Veteran's ischemic heart disease, prostate cancer (status post radical prostatectomy), and erectile dysfunction are all found to be related to his service due to exposure to herbicide agents during active duty. The erectile dysfunction is also found to be secondary to the service-connected prostate cancer.

The Board denied service connection for leukemia and prostate cancer, both presumed to be related to in-service exposure to herbicides or asbestos. The claims were not granted as the diseases are not linked to service.

Service connection for prostate cancer was granted with an effective date of August 1, 2009. The reduction in rating from 100% to 20% was affirmed. The issue of increased ratings for prostate cancer and residuals is still under consideration.

The Veteran does not have prostate cancer and the current prostate disabilities are not related to his active service, including herbicide exposure.

The Veteran's prostate cancer and diabetes mellitus are presumed to have been incurred as a result of his exposure to herbicides during service. The Board finds the Veteran set foot in Vietnam, establishing presumptive exposure.

The Veteran has been granted service connection for diabetes mellitus, type II and erectile dysfunction as a result of herbicide exposure in service.,Service connection was also granted for prostate cancer due to herbicide exposure.

The Veteran's appeal is being remanded for additional development, including a VA examination to address the issues on appeal and determine if there was any negligence or lack of proper care from VA in his prostate cancer treatment.

The Board found that the Veteran's service-connected inactive pulmonary tuberculosis did not contribute substantially or materially to his death, and thus denied DIC benefits.

The Board has remanded the case for further development, including obtaining medical opinions regarding the Veteran's claimed conditions and verifying herbicide exposure. The Veteran is seeking service connection for coronary artery disease, prostate cancer, and erectile dysfunction, all potentially related to herbicide exposure.

The Veteran's appeal is being remanded due to the need for a personal hearing on his claim of service connection for prostate disability.

The Veteran's cause of death was not related to service-connected conditions, and the criteria for Dependency and Indemnity Compensation under 38 U.S.C.A. § 1318 were not met.

The Board denied the Veteran's claims for service connection for bilateral hearing loss and prostate cancer, finding that there was no evidence of a current disability in either condition.

The Board found that the cause of the Veteran's death, prostate cancer with metastasis, was not related to his active service or any incident of service, including alleged in-service herbicide exposure. The claim for service connection for the cause of the Veteran's death is denied.

The Veteran's prostate cancer residuals are rated at a 60 percent disability rating since May 1, 2007 due to the need for absorbent materials which must be changed more than four times per day. The TDIU claim is not granted.

The Board has remanded the case due to incomplete records and need for additional opinions regarding service connection claims.

The Veteran's claim for compensation under 38 U.S.C.A. § 1151 due to radiation treatment at a VA facility is denied as there is no credible evidence of such treatment. The application to reopen the claim for service connection for loss of teeth with numbness is also denied.

The Veteran's prostate cancer has been rated at 10 percent since March 1, 2011. The Board is remanding the case to determine if a higher rating is warranted based on current severity of symptoms.

The Board has remanded the case due to the need for a VA opinion regarding the etiology of the Veteran's prostate cancer and related residuals, including erectile dysfunction. The issues are inextricably intertwined and must be addressed together.